People channel feed

Mis­sion pos­si­ble: As­traZeneca CEO So­ri­ot ral­lies the troops, promis­ing to fight on

8 years ago

Lat­est tes­ti­mo­ny in Shkre­li tri­al cen­ters on a Retrophin stock deal gone sour

8 years ago

Pas­cal So­ri­ot is stay­ing at As­traZeneca af­ter all, con­firm­ing up­com­ing pre­sen­ta­tion - re­ports

8 years ago

Glax­o­SmithK­line woos Pfiz­er med­i­c­i­nal sci­ences chief Tony Wood to high-lev­el R&D job

8 years ago

Ex-GSK CEO An­drew Wit­ty goes biotech, tak­ing a board seat at G1

8 years ago

Ter­ri­ble op­tics: As­traZeneca shares take a hit fol­low­ing re­port that CEO So­ri­ot is mov­ing to Te­va

8 years ago

Cel­gene vet Jack­ie Fouse grabs the reins of a Vivek Ra­maswamy vant-up

8 years ago
Startups

Fed­s' case spot­lights Shkre­li’s dis­as­trous biotech short -- which forced him to launch Retrophin

8 years ago

Court pa­pers out­line an an­gry show­down be­tween Pas­cal So­ri­ot and a de­part­ing Luke Miels

8 years ago

A judge or­ders Mar­tin Shkre­li to zip it -- af­ter Twit­ter shuts down his lat­est on­line ac­count

8 years ago

Shire’s Orn­skov dic­tates an­oth­er big re­vamp, with R&D/HQ mov­ing in­to Cam­bridge

8 years ago
Pharma

Ge­nius or chron­ic liar? The Mar­tin Shkre­li fraud tri­al gets un­der­way with two rad­i­cal­ly op­posed por­traits

8 years ago

Al­ler­gan vet Doug In­gram takes the helm of a storm-tossed Sarep­ta

8 years ago

Scoop: Mar­tin Shkre­li bats back a coup at Tur­ing, new board con­sid­ers a sale of as­sets

8 years ago

Af­ter months of taunts and tantrums, Mar­tin Shkre­li's fraud tri­al gets un­der­way

8 years ago

The End­points 100 CEO Sur­vey: Ex­ecs of­fer a big thumbs up for Got­tlieb and some sug­ges­tions for mak­ing the FDA a bet­ter agency

8 years ago
R&D

As­traZeneca and Glax­o­SmithK­line come to a peace­ful set­tle­ment of their tug of war over Luke Miels

8 years ago

Art Krieg comes down from the moun­tain with a $27M round for Check­mate Phar­ma­ceu­ti­cals

8 years ago
Financing
Startups

Lit­tle Aziyo is grow­ing a new re­gen­er­a­tive med com­pa­ny, led by some fa­mil­iar faces in the biz

8 years ago
Startups

With No­var­tis and Google jump­ing in, Medicxi un­veils a $300M late-stage biotech fund with a transat­lantic scope

8 years ago
Financing

Alex­ion's Hantson poach­es Bio­gen CFO Clan­cy as buzz of a loom­ing pipeline shake­up heats up

8 years ago

Top JP­Mor­gan in­vest­ment banker brings his tal­ents — and con­nec­tions — to the biotech start­up crew on board Flag­ship

8 years ago
Financing

Lit­tle Drag­on­fly bursts on­to the I/O scene with a $33M Cel­gene deal and some of the biggest names in biotech

8 years ago
Pharma

So what’s star Broad in­ves­ti­ga­tor Feng Zhang up to now?

8 years ago
First page Previous page 949596979899100 Next page Last page
A service from the Financial Times